Bioinformatics, Computational and Systems Biology
Programmable knockdown of target genes in polycistronic mRNA using de novo-designed sRNA
Eva Soler
Undergraduate Researcher
Columbia University, United States
Jaeseung Hahn
Postdoctoral Research Associate
Columbia University, United States
Krishnaveni Dole
Undergraduate Researcher
Columbia University, United States
Tasfia Haque
Undergraduate Researcher
Stony Brook University, United States
Tal Danino
Principal Investigator
Columbia University, United States
Fluorescence results demonstrate that the first sRNA tested was successful at silencing genes in the polycistronic mRNA without mRNA degradation. The sRNA silenced mTag and mCherry at different rates. In the reporter, mTag had a naturally higher expression since it is the first gene translated in the mRNA and doesn’t require dimerization like mCherry. For these reasons, the fluorescence signal continued to be reflected on the read after introducing the sRNA. On the other hand, mCherry also experienced silencing but not as significantly as mTag. Monitoring the net signal over time also provided more information about this phenomenon, showing that gene silencing is temporary as the fluorescent signal recovers after 4 hours.
This information has facilitated preliminary conclusions on how we can apply our designs to better control gene expression levels and optimize sRNAs to generate a personalized sRNA control system for prokaryotes. With the sRNAs currently being tested, we hope to explore different possible routes for the sRNA’s inability to knock down certain genes, and silencing genes with or without target mRNA degradations.
Gaining a deeper understanding of how artificial sRNA works in the context of polycistronic mRNA could lead to the seamless application of sRNAs to control gene expression and improve the safety and efficacy of therapeutic microbes. Ultimately, the successful understanding and application of sRNAs in polycistronic mRNA would allow for the personalized control of natural genetic systems, which has the potential to open many exciting opportunities for their application in the biomedical field. The next steps for this project involve collecting data from the rest of the sRNA designs as well as testing different combinations and dilutions of the sRNAs in a host cell to identify their efficiency thresholds and how they may complement each other. Another avenue we are excited to explore is to apply newly developed generative AI methods for protein expression and engineering to help us expand our panel of sRNAs.
Our research is supported by Professor Tal Danino and Post-doctoral Research Associate Jaeseung Hahn in the Department of Biomedical Engineering at Columbia University. Figures were made using BioRender and Prism 9.
[1] Hui, C.-Y., Guo, Y., Zhang, W., & Huang, X.-Q. (2018). Rapid monitoring of the target protein expression with a fluorescent signal based on a dicistronic construct in escherichia coli. AMB Express, 8(1). https://doi.org/10.1186/s13568-018-0612-5
[2]Kim, J., Zhou, Y., Carlson, P. D., Teichmann, M., Chaudhary, S., Simmel, F. C., Silver, P. A., Collins, J. J., Lucks, J. B., Yin, P., & Green, A. A. (2019). De novo-designed translation-repressing riboregulators for multi-input cellular logic. Nature Chemical Biology, 15(12), 1173–1182. https://doi.org/10.1038/s41589-019-0388-1
[3] Komarova, E. S., Chervontseva, Z. S., Osterman, I. A., Evfratov, S. A., Rubtsova, M. P., Zatsepin, T. S., Semashko, T. A., Kostryukova, E. S., Bogdanov, A. A., Gelfand, M. S., Dontsova, O. A., & Sergiev, P. V. (2020). Influence of the spacer region between the shine–dalgarno box and the start codon for fine‐tuning of the translation efficiency in escherichia coli. Microbial Biotechnology, 13(4), 1254–1261. https://doi.org/10.1111/1751-7915.13561
[4] Noh, M., Yoo, S. M., Kim, W. J., & Lee, S. Y. (2017). Gene expression knockdown by modulating synthetic small RNA expression in escherichia coli. Cell Systems, 5(4). https://doi.org/10.1016/j.cels.2017.08.016
[5]Yoo, S. M., Na, D., & Lee, S. Y. (2013). Design and use of synthetic regulatory small RNAS to control gene expression in escherichia coli. Nature Protocols, 8(9), 1694–1707. https://doi.org/10.1038/nprot.2013.105
[6]Harimoto, T., Hahn, J., Chen, YY. et al. A programmable encapsulation system improves delivery of therapeutic bacteria in mice. Nat Biotechnol 40, 1259–1269 (2022). https://doi.org/10.1038/s41587-022-01244-y